United States · FDA National Drug Code directory
Natazia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-409_3b747381-9764-44a3-a08d-a80cf0988665
- Product NDC
- 50419-409
- Form
- KIT
- Composition / generic term
- estradiol valerate and estradiol valerate/dienogest
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20100506
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 90 BLISTER PACK in 1 PACKAGE (50419-409-00) / 1 KIT in 1 BLISTER PACK · 50419-409-00
- 3 BLISTER PACK in 1 PACKAGE (50419-409-03) / 1 KIT in 1 BLISTER PACK (50419-409-01) · 50419-409-03
- 5 BLISTER PACK in 1 PACKAGE (50419-409-73) / 1 KIT in 1 BLISTER PACK · 50419-409-73
- 2 BLISTER PACK in 1 PACKAGE (50419-409-76) / 1 KIT in 1 BLISTER PACK (50419-409-70) · 50419-409-76
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →